Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

Leukemia. 2014 Jul;28(7):1552-5. doi: 10.1038/leu.2014.66. Epub 2014 Feb 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calreticulin / genetics*
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Mutation*
  • Primary Myelofibrosis / genetics*
  • Primary Myelofibrosis / mortality*
  • Primary Myelofibrosis / therapy
  • Prognosis
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Calreticulin